As the program advances toward clinical trials, Amogen continues to invest in its peptide and biosimilar manufacturing infrastructure, positioning the company to meet growing global demand for affordable GLP-1 therapies
Normally, when you eat, GLP-1 is released naturally and has the following actions: Signals the stomach to release food slowly Stimulates the pancreas to stop releasing glucagon, and start releasing insulin to prepare for a spike in blood sugar (Eventually) travels to the brain and acts on several areas involved in appetite regulation, shutting down the desire for food These are powerful effects, but they are tempered by the fact that GLP-1 doesnt stick around for very long
FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 29 (6), 22682280
Its been amazing to feel more vibrant and less drained
Early clinical data suggests its potency may significantly surpass current treatments, but with greater power comes a greater risk of rapid muscle loss